WHO Working Group – Core Protocol for vaccines against COVID-19
17 April 2020
| Publication

Overview
Recognizing the critical importance to world health of the rapid availability and deployment of effective vaccines against COVID-19 the Working Group on the core protocol for vaccines against COVID-19 aims to provide a phase 2b/3 protocol that will enable the concurrent evaluation of the benefits and risks of each promising candidate vaccines. The objectives of this group are to:
- Outline the key aims of the protocol
- Outline the key benefits of the protocol
- Develop a protocol synopsis.
- Develop a core protocol for phase 2b, phase 3 efficacy trials of vaccines against COVID-19.
- Prepare and be available for the regular working group calls.
- Provide technical advice and support the WHO Secretariat through comments and or feedback from stakeholders
WHO Team
R&D Blue Print (RDB)
Number of pages
4